Response Genetics Reports Second Quarter 2007 Financi... ($ 3115378 Operating expenses: Cost...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Response Genetics Reports Second Quarter 2007 Financial Results

Date:8/19/2007

$ 3,115,378

Operating expenses:

Cost of revenue 584,230 1,183,312 978,130 2,006,152

General and

administrative 659,246 1,924,816 1,577,385 3,187,882

Research and

development 269,247 916,793 595,702 1,237,215

Total operating

expenses 1,512,723 4,024,921 3,151,217 6,431,249

Operating income

(loss) (774,573) (2,529,303) (1,144,092) (3,315,871)

Other income

(expense):

Interest expense (14,954) (14,506) (29,878) (26,756)

Interest income 42,565 66,655 75,218 108,331

Other - - 179,000 -

Income (loss) before

income taxes (746,962) (2,477,154) (919,752) (3,234,296)

Provision for income

taxes - 7,269 800 8,069

Net income (loss) (746,962) (2,484,423) (920,552) (3,242,365)

Preferred stock

dividends 233,562 179,064 467,123 412,625

Net income (loss)

attributable to

common stockholders $(980,524) $(2,663,487) $(1,387,675)$ (3,654,990)

Net income (loss)

per share-basic $ (0.36) $ (0.58) $ (0.51) $ (1.00)

Net income (loss)

per share-diluted $ (0.36) $ (0.58) $ (0.51) $ (1.00)

Weighted-average

shares- basic 2,726,320 4,562,815 2,726,320 3,644,568

Weighted-average

shares-diluted 2,726,320 4,562,815 2,726,320 3,644,568

SOURCE Response Genetics, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
2. FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses
3. IT critical in pandemic response, but many are not paying attention
4. Quick response manufacturing and biotech
5. Wisconsin court affirms damages in Innogenetics, Abbott patent case
6. Third Wave licenses Innogenetics tech to settle lawsuit
7. Symposium examines the effect of race on genetics and disease
8. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
9. Sonic Foundry reports GAAP loss as Q2 revenues rise
10. Fiserv reports $113.5 million in Q1 profit
11. Third Wave reports net loss of $18.9M for 2006

Post Your Comments:

Breaking Biology Technology:BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2 BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3 CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2 CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3 New antioxidant compounds have been identified in foods such as olive oil, honey and nuts 2 Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes 2

[0] BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes [0] CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner [0] New antioxidant compounds have been identified in foods such as olive oil, honey and nuts [0] Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes

Other Biology Technology:GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development 2 GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development 3 GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development 4 Quintiles Consulting Business Expands 2 Quintiles Consulting Business Expands 3 Quintiles Consulting Business Expands 4 AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia 2 AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia 3 AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia 4 AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia 5

GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development Quintiles Consulting Business Expands AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia

Breaking Biology News(10 mins):ADA releases updated position paper on nutrient supplementation 2 Small addition to cancer drug may make big difference 2 Small addition to cancer drug may make big difference 3 U. of I. business instructional facility achieves top 'green' standard 2 U. of I. business instructional facility achieves top 'green' standard 3 Custom Spine Announces New Board of Directors and CFO 52778 1 Custom Spine Announces New Board of Directors and CFO 52778 2 Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 1 Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 2 Digitas Health Expands Adding Two Key Locations 13208 1 Digitas Health Expands Adding Two Key Locations 13208 2 Digitas Health Expands Adding Two Key Locations 13208 3 Digitas Health Expands Adding Two Key Locations 13208 4

[0] ADA releases updated position paper on nutrient supplementation [0] Small addition to cancer drug may make big difference [0] U. of I. business instructional facility achieves top 'green' standard

Other Biology News:Huddling and a drop in metabolism allow penguins to survive the South Pole cold 2 Huddling and a drop in metabolism allow penguins to survive the South Pole cold 3 Huddling and a drop in metabolism allow penguins to survive the South Pole cold 4 Prion disease treatable if caught early 2 Stress hormones may play new role in speeding up cancer growth 2 Stress hormones may play new role in speeding up cancer growth 3

Huddling and a drop in metabolism allow penguins to survive the South Pole cold Prion disease treatable if caught early Stress hormones may play new role in speeding up cancer growth

Biology Products:

Equine TNF-alpha (TNFSF1A) ELISA development Kit, DuoSet from R&D Systems Canine IFN-gamma ELISpot Development Kit from R&D Systems Porcine IFN-gamma ELISpot Development Kit from R&D Systems DETACHaBEAD CD19 from Dynal Biotech